SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 230 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,710,491 | -13.8% | 47,212 | -15.1% | 0.04% | +17.6% |
| Q4 2022 | $1,983,537 | -2.1% | 55,608 | -7.1% | 0.03% | 0.0% |
| Q3 2022 | $2,026,000 | +248.7% | 59,838 | +232.7% | 0.03% | +209.1% |
| Q1 2022 | $581,000 | +13.7% | 17,986 | +8.4% | 0.01% | +22.2% |
| Q2 2021 | $511,000 | -31.4% | 16,588 | -41.7% | 0.01% | -30.8% |
| Q1 2021 | $745,000 | +127.1% | 28,454 | +118.1% | 0.01% | +116.7% |
| Q4 2020 | $328,000 | -4.7% | 13,045 | -20.9% | 0.01% | -40.0% |
| Q3 2020 | $344,000 | -6.5% | 16,500 | +6.5% | 0.01% | -44.4% |
| Q2 2020 | $368,000 | – | 15,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |